Delivery Order SPE2DR25D1002-SPE2DR26FGJ5E
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Copaxone 40 mg/ml syringes under a firm fixed-price contract valued at $7,950.72. This is a non-set-aside competitive award with an ultimate completion date of August 26, 2025, and performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. Copaxone is a disease-modifying therapy used in the treatment of multiple sclerosis, and this delivery...
- The Defense Logistics Agency awarded a $1,638.00 delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with a completion date of September 10, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,218.86 to supply Copaxone 40 mg/mL syringes. This competitively awarded, firm fixed-price contract, issued on October 15, 2025, with an ultimate completion date of October 16, 2025, represents a direct fulfillment of pharmaceutical needs through the company's existing indefinite delivery vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,683.86 to AmerisourceBergen Drug Corp for Copaxone 20 mg/ml syringes, with a completion date of August 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and operates as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Copaxone 40 mg/ml syringes valued at $6,552.00, with an ultimate completion date of October 30, 2025. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes with a ceiling value of $6,552.00 under a firm fixed price contract type. The delivery order was issued on October 29, 2025, with an ultimate completion date of October 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was utilized for this award, indicating the contract was competitively awarded. This delivery...
- The Defense Logistics Agency awarded a $15,154.14 delivery order to AmerisourceBergen Drug Corp for the supply of Copaxone 20 mg/ml syringes. The contract, which was competitively awarded without set-aside designation, became effective on April 21, 2025, with an ultimate completion date of April 22, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a firm fixed-price delivery order, this award represents a discrete fulfillment...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Copaxone 40 mg/ml syringes with a ceiling value of $3,864.84 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,730.00 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Copaxone 40 mg/mL syringes. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the company's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,065.20 to AmerisourceBergen Drug Corp for the supply of Copaxone 40 mg/ml syringes. This non-competitive, firm fixed-price delivery order was issued on October 30, 2025, with an ultimate completion date of October 31, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor. This...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGJ5EDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Copaxone 40 mg/mL syringes with a ceiling value of $2,146.06 and an ultimate completion date of November 10, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a major distribution hub for federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Copaxone, a disease-modifying therapy used in multiple sclerosis treatment, represents a routine procurement under this expansive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/7/25 |